Cargando…
Design, Synthesis and Biological Evaluation of 6,7-Disubstituted-4-phenoxyquinoline Derivatives Bearing Pyridazinone Moiety as c-Met Inhibitors
Deregulation of the receptor tyrosine kinase mesenchymal epithelial transition factor (MET) has been implicated in several human cancers and is an attractive target for small molecule drug discovery. Herein, a series of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing pyridazinone derivative...
Autores principales: | Liu, Xiaobo, Kou, Jianlan, Xiao, Zhen, Tian, Fajuan, Hu, Jiayi, Zheng, Pengwu, Zhu, Wufu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099740/ https://www.ncbi.nlm.nih.gov/pubmed/29949931 http://dx.doi.org/10.3390/molecules23071543 |
Ejemplares similares
-
Discovery of novel quinazoline derivatives bearing semicarbazone moiety as potent EGFR kinase inhibitors
por: Tu, Yuanbiao, et al.
Publicado: (2018) -
Research Progress of Small Molecule VEGFR/c-Met Inhibitors as Anticancer Agents (2016–Present)
por: Zhang, Qian, et al.
Publicado: (2020) -
Discovery of Triazolo-pyridazine/-pyrimidine Derivatives
Bearing Aromatic (Heterocycle)-Coupled Azole Units as Class II c-Met
Inhibitors
por: Zhang, Qian, et al.
Publicado: (2020) -
Design, Synthesis, and Biological Evaluation of [1,2,4]triazolo[4,3-a] Pyrazine Derivatives as Novel Dual c-Met/VEGFR-2 Inhibitors
por: Liu, Xiaobo, et al.
Publicado: (2022) -
Design, Synthesis, and Biological Evaluation of Pyridazinones Containing the (2-Fluorophenyl) Piperazine Moiety as Selective MAO-B Inhibitors
por: Çeçen, Muhammed, et al.
Publicado: (2020)